Astragaloside IV drug-loaded exosomes (AS-IV EXOs) derived from endothelial progenitor cells improve the viability and tube formation in high-glucose impaired human endothelial cells by promoting miR-214 expression.

IF 2 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM
X. Zou, Huidongzi Xiao, Xuesong Bai, Yixian Zou, Wenxiao Hu, Xiangdong Lin, Chenhong Zhu, Yao Liang, Wu Xiong
{"title":"Astragaloside IV drug-loaded exosomes (AS-IV EXOs) derived from endothelial progenitor cells improve the viability and tube formation in high-glucose impaired human endothelial cells by promoting miR-214 expression.","authors":"X. Zou, Huidongzi Xiao, Xuesong Bai, Yixian Zou, Wenxiao Hu, Xiangdong Lin, Chenhong Zhu, Yao Liang, Wu Xiong","doi":"10.5603/EP.a2022.0011","DOIUrl":null,"url":null,"abstract":"INTRODUCTION\nThe high glucose changes caused by diabetes mellitus (DM) can damage the vascular system. Astragaloside IV (AS-IV) can improve diabetes and promote angiogenesis. Exosomes (EXOs) help to carry specific drugs into cells efficiently. However, whether AS-IV loaded EXOs (AS-IV EXOs) can improve damaged endothelial cells through miR-214 remains to be determined.\n\n\nMATERIAL AND METHODS\nWe prepared and identified AS-IV EXOs derived from endothelial progenitor cells (EPCs) and high glucose stimulated endothelial cell models to investigate whether AS-IV EXOs can improve damaged endothelial cells through miR-214. We used a transmission electron microscope (TEM) and DAPI staining to identify the morphology and characteristic expression of EPCs and EXOs, and then prepared AS-IV EXOs. Cell function tests were performed to detect the cloning, proliferation, and migration capabilities of cells. Western blot (WB) and real-time quantitative polymerase chain reaction (qRT-PCR) were used to assess the expression level of Tie-2, Ang-1, and PI3K/Akt-related protein.\n\n\nRESULTS\nThe DAPI staining results showed that inducing human umbilical vein endothelial cells (HUVECs) could effectively absorb AS-IV EXOs. The results of plate clone formation assay, CCK-8, cell adhesion, and transwell assay of HUVECs stimulated by high glucose showed that AS-IV EXOs had a damage relief effect. By the detection of WB and qRT-PCR, it was found that AS-IV EXOs promoted the expression of miR-214 and proteins related to blood vessel growth. After transfection of miR-214 to pre-treat HUVECs under high glucose stimulation, AS-IV EXOs promoted the tube formation of HUVECs by regulating the level of miR-214.\n\n\nCONCLUSIONS\nBy promoting the expression of miR-214, AS-IV EXOs significantly improved the activity and tubularization of HUVECs under high glucose stimulation.","PeriodicalId":11551,"journal":{"name":"Endokrynologia Polska","volume":"73 2 1","pages":"336-345"},"PeriodicalIF":2.0000,"publicationDate":"2022-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endokrynologia Polska","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5603/EP.a2022.0011","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 1

Abstract

INTRODUCTION The high glucose changes caused by diabetes mellitus (DM) can damage the vascular system. Astragaloside IV (AS-IV) can improve diabetes and promote angiogenesis. Exosomes (EXOs) help to carry specific drugs into cells efficiently. However, whether AS-IV loaded EXOs (AS-IV EXOs) can improve damaged endothelial cells through miR-214 remains to be determined. MATERIAL AND METHODS We prepared and identified AS-IV EXOs derived from endothelial progenitor cells (EPCs) and high glucose stimulated endothelial cell models to investigate whether AS-IV EXOs can improve damaged endothelial cells through miR-214. We used a transmission electron microscope (TEM) and DAPI staining to identify the morphology and characteristic expression of EPCs and EXOs, and then prepared AS-IV EXOs. Cell function tests were performed to detect the cloning, proliferation, and migration capabilities of cells. Western blot (WB) and real-time quantitative polymerase chain reaction (qRT-PCR) were used to assess the expression level of Tie-2, Ang-1, and PI3K/Akt-related protein. RESULTS The DAPI staining results showed that inducing human umbilical vein endothelial cells (HUVECs) could effectively absorb AS-IV EXOs. The results of plate clone formation assay, CCK-8, cell adhesion, and transwell assay of HUVECs stimulated by high glucose showed that AS-IV EXOs had a damage relief effect. By the detection of WB and qRT-PCR, it was found that AS-IV EXOs promoted the expression of miR-214 and proteins related to blood vessel growth. After transfection of miR-214 to pre-treat HUVECs under high glucose stimulation, AS-IV EXOs promoted the tube formation of HUVECs by regulating the level of miR-214. CONCLUSIONS By promoting the expression of miR-214, AS-IV EXOs significantly improved the activity and tubularization of HUVECs under high glucose stimulation.
源自内皮祖细胞的黄芪甲苷载药外泌体(AS-IV EXOs)通过促进miR-214的表达,改善高糖受损的人内皮细胞的活力和管的形成。
引言糖尿病引起的高血糖变化会损害血管系统。黄芪甲苷IV(AS-IV)可改善糖尿病,促进血管生成。外泌体(EXO)有助于有效地将特定药物携带到细胞中。然而,AS-IV负载的EXO(AS-IV EXO)是否可以通过miR-214改善受损的内皮细胞仍有待确定。材料和方法我们制备并鉴定了来源于内皮祖细胞(EPC)和高糖刺激的内皮细胞模型的AS-IV EXO,以研究AS-IV EX是否可以通过miR-214改善受损的内皮细胞。我们使用透射电子显微镜(TEM)和DAPI染色来鉴定EPCs和EXOs的形态和特征表达,然后制备AS-IV EXOs。进行细胞功能测试以检测细胞的克隆、增殖和迁移能力。Western印迹(WB)和实时定量聚合酶链反应(qRT-PCR)用于评估Tie-2、Ang-1和PI3K/Akt相关蛋白的表达水平。结果DAPI染色结果表明,诱导人脐静脉内皮细胞(HUVECs)能有效吸收AS-IV EXOs。平板克隆形成试验、CCK-8、细胞粘附和高糖刺激的HUVECs的transwell试验结果表明,AS-IV EXOs具有减轻损伤的作用。通过WB和qRT-PCR检测,发现AS-IV EXOs促进了miR-214和与血管生长相关的蛋白质的表达。在高糖刺激下转染miR-214预处理HUVECs后,AS-IV EXOs通过调节miR-214的水平促进HUVECs的管形成。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Endokrynologia Polska
Endokrynologia Polska ENDOCRINOLOGY & METABOLISM-
CiteScore
2.60
自引率
9.50%
发文量
129
审稿时长
6-12 weeks
期刊介绍: "Endokrynologia Polska" publishes papers in English on all aspects of clinical and experimental endocrinology. The following types of papers may be submitted for publication: original articles, reviews, case reports, postgraduate education, letters to the Editor (Readers’ Forum) and announcements of scientific meetings, conferences and congresses.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信